Vera Therapeutics (VERA) Treasury Shares (2020 - 2026)
Vera Therapeutics posted quarterly Treasury Shares of $2.1 million for Q1 2026, up 83.26% year-on-year from $1.2 million in Q1 2025, and up 32.38% on a QoQ basis from $1.6 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 83.26% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 83.26% YoY), and the FY2025 full-year result was $1.6 million, up 129.57% from the prior year.
- Treasury Shares for Q1 2026 stood at $2.1 million, up from $1.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.1 million in Q1 2026 and bottomed at $4450.0 in Q3 2024.
- The 5-year median for Treasury Shares is $235180.0 (2022), against an average of $626602.5.
- The widest annual swing landed in 2024, when Treasury Shares plunged 96.64%; it then surged 33864.49% in 2025.
- A 5-year view of Treasury Shares shows it stood at $204000.0 in 2022, then plunged by 35.45% to $131679.0 in 2023, then soared by 429.23% to $696888.0 in 2024, then soared by 129.57% to $1.6 million in 2025, then surged by 32.38% to $2.1 million in 2026.
- The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 696,888.00 |
| Dec 31, 2024 | 696,888.00 |
| Sep 30, 2024 | 4,450.00 |
| Sep 30, 2024 | 4,450.00 |
| Jun 30, 2024 | 493,834.00 |
| Jun 30, 2024 | 493,834.00 |
| Mar 31, 2024 | 472,325.00 |
| Mar 31, 2024 | 472,325.00 |
| Dec 31, 2023 | 131,679.00 |
| Dec 31, 2023 | 131,679.00 |
| Sep 30, 2023 | 132,616.00 |
| Sep 30, 2023 | 132,616.00 |
| Jun 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 203,500.00 |
| Mar 31, 2023 | 203,500.00 |
| Dec 31, 2022 | 204,000.00 |
| Dec 31, 2022 | 204,000.00 |
| Sep 30, 2022 | 235,180.00 |
| Sep 30, 2022 | 235,180.00 |
| Jun 30, 2022 | 53,860.00 |
| Jun 30, 2022 | 53,860.00 |
| Mar 31, 2022 | 58,290.00 |
| Mar 31, 2022 | 58,290.00 |
| Dec 31, 2021 | 77,719.00 |
| Dec 31, 2021 | 77,719.00 |
| Sep 30, 2021 | 4,137.00 |
| Sep 30, 2021 | 4,137.00 |
| Jun 30, 2021 | 16,546.00 |
| Jun 30, 2021 | 16,546.00 |
| Mar 31, 2021 | 28,955.00 |
| Mar 31, 2021 | 28,955.00 |
| Dec 31, 2020 | 41,363.00 |
| Dec 31, 2020 | 41,363.00 |